169 related articles for article (PubMed ID: 3729200)
1. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity.
Shear NH; Spielberg SP; Grant DM; Tang BK; Kalow W
Ann Intern Med; 1986 Aug; 105(2):179-84. PubMed ID: 3729200
[TBL] [Abstract][Full Text] [Related]
2. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.
Rieder MJ; Shear NH; Kanee A; Tang BK; Spielberg SP
Clin Pharmacol Ther; 1991 Jan; 49(1):13-7. PubMed ID: 1988235
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism.
Spielberg SP
J Pharmacokinet Biopharm; 1996 Oct; 24(5):509-19. PubMed ID: 9131488
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.
Rieder MJ; Uetrecht J; Shear NH; Cannon M; Miller M; Spielberg SP
Ann Intern Med; 1989 Feb; 110(4):286-9. PubMed ID: 2913915
[TBL] [Abstract][Full Text] [Related]
5. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.
Wolkenstein P; Charue D; Laurent P; Revuz J; Roujeau JC; Bagot M
Arch Dermatol; 1995 May; 131(5):544-51. PubMed ID: 7741540
[TBL] [Abstract][Full Text] [Related]
6. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.
Rieder MJ; Uetrecht J; Shear NH; Spielberg SP
J Pharmacol Exp Ther; 1988 Feb; 244(2):724-8. PubMed ID: 3346843
[TBL] [Abstract][Full Text] [Related]
8. Predisposition to phenytoin hepatotoxicity assessed in vitro.
Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
[TBL] [Abstract][Full Text] [Related]
9. Glutathione synthetase-deficient lymphocytes and acetaminophen toxicity.
Spielberg SP; Gordon GB
Clin Pharmacol Ther; 1981 Jan; 29(1):51-5. PubMed ID: 7460474
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of a toxic metabolite of sulfadiazine.
Shear NH; Spielberg SP
Can J Physiol Pharmacol; 1985 Nov; 63(11):1370-2. PubMed ID: 4075255
[TBL] [Abstract][Full Text] [Related]
11. Time-course of toxicity of reactive sulfonamide metabolites.
Rieder MJ; Krause R; Bird IA
Toxicology; 1995 Jan; 95(1-3):141-6. PubMed ID: 7825180
[TBL] [Abstract][Full Text] [Related]
12. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
Walker DK; Alabaster CT; Congrave GS; Hargreaves MB; Hyland R; Jones BC; Reed LJ; Smith DA
Drug Metab Dispos; 1996 Apr; 24(4):447-55. PubMed ID: 8801060
[TBL] [Abstract][Full Text] [Related]
13. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
14. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine.
Cribb AE; Spielberg SP
Drug Metab Dispos; 1990; 18(5):784-7. PubMed ID: 1981737
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides.
Gupta A; Eggo MC; Uetrecht JP; Cribb AE; Daneman D; Rieder MJ; Shear NH; Cannon M; Spielberg SP
Clin Pharmacol Ther; 1992 Jan; 51(1):56-67. PubMed ID: 1732077
[TBL] [Abstract][Full Text] [Related]
16. Acetylation.
Weber WW
Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
[TBL] [Abstract][Full Text] [Related]
17. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility.
Kearns GL; Wheeler JG; Childress SH; Letzig LG
J Pediatr; 1994 Nov; 125(5 Pt 1):805-11. PubMed ID: 7965438
[TBL] [Abstract][Full Text] [Related]
18. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism].
Furet Y; Bechtel Y; Le Guellec C; Bechtel PR; Autret-Leca E; Paintaud G
Therapie; 2002; 57(5):427-31. PubMed ID: 12611196
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
20. Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine.
Frederick CB; Weis CC; Flammang TJ; Martin CN; Kadlubar FF
Carcinogenesis; 1985 Jul; 6(7):959-65. PubMed ID: 4017176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
